Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.41 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.41 |
| ▸ | ACHE | P22303 | 6/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL196972 | 0.83 | ALDH1A1 (0.43) | LMNAALDH1A1HSD17B10MAPT | |
| SCHEMBL196971 | 0.83 | ALDH1A1 (0.43) | LMNAALDH1A1HSD17B10MAPT | |
| SCHEMBL15305328 | 0.80 | NAAA (0.52) | LMNAALDH1A1TSHRACHEDNM1 | |
| SCHEMBL15305326 | 0.80 | NAAA (0.52) | LMNAALDH1A1TSHRACHEDNM1 | |
| Dodecanol SCHEMBL28520384 | 0.80 | TSHR (0.50) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL15796319 | 0.80 | NAAA (0.52) | LMNAALDH1A1TSHRACHEDNM1 | |
| SCHEMBL15796587 | 0.80 | NAAA (0.52) | LMNAALDH1A1TSHRACHEDNM1 | |
| SCHEMBL453610 | 0.80 | NAAA (0.52) | LMNAALDH1A1TSHRACHEDNM1 | |
| SCHEMBL21184186 | 0.80 | NAAA (0.52) | LMNAALDH1A1TSHRACHEDNM1 | |
| SCHEMBL138880 | 0.80 | NAAA (0.52) | LMNAALDH1A1TSHRACHEDNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1837187-A | Crystalline salts of dodecyl 2-(n,n-dimethylamino)-propionate | NEXMED HOLDINGS INC (US) | 2006-09-27 | — | — | CN | disclosed |
| EP-1278495-A4 | TOPICAL COMPOSITIONS CONTAINING PROSTAGLANDIN E 1? | NEXMED HOLDINGS INC (US) | 2006-03-22 | — | — | EP | disclosed |
| CN-1244546-C | Crystalline salts of dodecyl 2- (N, N-dimethylamino) -propionate | NEXMED HOLDINGS INC (US) | 2006-03-08 | — | — | CN | disclosed |
| CN-1733706-A | Crystalline salts of dodecyl 2-(n,n-dimethylamino)-propionate | NEXMED HOLDINGS INC (US) | 2006-02-15 | — | — | CN | disclosed |
| EP-1278495-A1 | TOPICAL COMPOSITIONS CONTAINING PROSTAGLANDIN E 1? | Nexmed Holdings, Inc. (US) | 2003-01-29 | — | — | EP | disclosed |
| WO-2001074279-A1 | TOPICAL COMPOSITIONS CONTAINING PROSTAGLANDIN E¿1? | NEXMED HOLDINGS, INC. (US) | 2001-10-11 | — | — | WO | disclosed |
| CN-1306502-A | Crystalline salts of dodecyl 2- (N, N-dimethylamino) -propionate | NEXMED HOLDINGS INC (US) | 2001-08-01 | — | — | CN | disclosed |